AKT1 and cancer: Both up and down miRNA targets were enriched with RNA catabolic process (GO:0006401), and transcription co-regulator activity (GO:0003712), MAPK signaling pathway (hsa04010), PI3K-Akt signaling pathway (hsa04151), and proteoglycans in cancer (hsa05205).